BPC Analysis of Government Funding for Cures Act, Upcoming FDA Bill in Health

Washington, D.C.– Last Friday, President Trump signed into law the bipartisan Consolidated Appropriations Act of 2017, also known as the omnibus spending bill. This legislation provides considerable funding to support the implementation of the 21st Century Cures Act, which will accelerate safe and effective treatments and cures for patients.

This week, the Senate Health, Education, Labor, and Pensions (HELP) Committee is expected to mark-up the FDA Reauthorization Act of 2017, which is bipartisan legislation reauthorizing FDA user fees for prescription drugs, devices, and biosimilars over the next five years.

BPC’s just-released report, Accelerating the Development and Delivery of Safe and Effective Cures for Patients in the United States, offers recommendations to help inform Congress as it finalizes and passes legislation in the coming weeks.